Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs TransMedics Group Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $94.83, while TransMedics Group Inc trades at $89.19 (market cap $3.10B). Which is the better fit depends on your goals.
| EMB | TMDX | |
|---|---|---|
Sector | Fixed Income | Technology |
52-Week High | $97.74 | $150.42 |
52-Week Low | $92.95 | $61.99 |
Market Cap | — | $3.10B |
Enterprise Value | — | $3.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
